Per Omvik

12.2k citations

125 papers · 8.7k indexed · 2 hit papers · h-index 27

Impact in

Cardiology and Cardiovascular Medicine top 0.1%
- Blood Pressure and Hypertension Studies
- Renin-Angiotensin System Studies
- Heart Rate Variability and Autonomic Control
- Cardiovascular Function and Risk Factors
- Cardiovascular Health and Disease Prevention
- Heart Failure Treatment and Management
Endocrinology, Diabetes and Metabolism top 0.2%
- Hormonal Regulation and Hypertension

Papers in ⓘ

Cardiology and Cardiovascular Medicine 96
- Blood Pressure and Hypertension Studies 82
- Heart Rate Variability and Autonomic Control 35
- Cardiovascular Function and Risk Factors 14
- Renin-Angiotensin System Studies 9
Complementary and alternative medicine 30
- Cardiovascular and exercise physiology 30

Co-authors: Sverre E. Kjeldsen (25 shared papers)Stevo Julius (18 shared papers)Markku S. Nieminen (24 shared papers)Lars Lindholm (23 shared papers)Hans Ibsen (23 shared papers)Ole Lederballe‐Pedersen (21 shared papers)Richard B. Devereux (21 shared papers)Frej Fyhrquist (17 shared papers)
Journals: Journal of Hypertension (18 papers)Blood Pressure (15 papers)Journal of Cardiovascular Pharmacology (8 papers)Hypertension (8 papers)Cardiovascular Drugs and Therapy (5 papers)
Partner nations: Norway United States Sweden

In The Last Decade

Per Omvik

123 papers receiving 8.1k citations

Hit Papers

align trajectories log scale

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol 2002 · 3.9k citations

Peers

Countries citing papers authored by Per Omvik

Since Specialization

Citations

This map shows the geographic impact of Per Omvik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Omvik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Omvik more than expected).

Fields of papers citing papers by Per Omvik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Omvik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Omvik. The network helps show where Per Omvik may publish in the future.

Co-authors

The 25 scholars most cited alongside Per Omvik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Per Omvik Line = papers co-authored together Per Omvik links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol The Lancet ·Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen, Stevo Julius, Gareth Beevers, Ulf dé Fairé, Frej Fyhrquist, Hans Ibsen, Krister Kristiansson, Ole Lederballe‐Pedersen, Lars Lindholm, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel Hit paper breakdown →	2002	3908
2	Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol The Lancet ·Lars Lindholm, Hans Ibsen, Björn Dahlöf, Richard B. Devereux, Gareth Beevers, Ulf dé Fairé, Frej Fyhrquist, Stevo Julius, Sverre E. Kjeldsen, Krister Kristiansson, Ole Lederballe‐Pedersen, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel, Peter Aurup, Jonathan M. Edelman, Steven Snapinn Hit paper breakdown →	2002	1094
3	Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients Hypertension ·Hans Ibsen, Michael Hecht Olsen, Kristian Wachtell, Knut Borch‐Johnsen, Lars Lindholm, Carl Erik Mogensen, Björn Dahlöf, Richard B. Devereux, Ulf dé Fairé, Frej Fyhrquist, Stevo Julius, Sverre E. Kjeldsen, Ole Lederballe‐Pedersen, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Ying Wan	2005	405
4	The impact of serum uric acid on cardiovascular outcomes in the LIFE study Kidney International ·Aud Høieggen, Michael H. Alderman, Sverre E. Kjeldsen, Stevo Julius, Richard B. Devereux, Ulf de Faire, Frej Fyhrquist, Hans Ibsen, Krister Kristianson, Ole Lederballe‐Pedersen, Lars Lindholm, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel, Cong Chen, Björn Dahlöf, for the LIFE Study Group	2004	368
5	Effects of Losartan on Cardiovascular Morbidity and Mortality in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy JAMA ·Sverre E. Kjeldsen, Björn Dahlöf, Richard B. Devereux, Stevo Julius, Peter Aurup, Jonathan M. Edelman, Gareth Beevers, Ulf dé Fairé, Frej Fyhrquist, Hans Ibsen, Krister Kristianson, Ole Lederballe‐Pedersen, Lars Lindholm, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Steven Snapinn, Hans Wedel, for the LIFE Study Group	2002	302
6	Characteristics of 9194 Patients With Left Ventricular Hypertrophy Hypertension ·Björn Dahlöf, Richard B. Devereux, Stevo Julius, Sverre E. Kjeldsen, Gareth Beevers, Ulf dé Fairé, Frej Fyhrquist, Thomas Hedner, Hans Ibsen, Krister Kristianson, Ole Lederballe‐Pedersen, Lars Lindholm, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel	1998	258
7	How smoking affects blood pressure Blood Pressure ·Per Omvik	1996	169
8	Left Atrial Size and Risk of Major Cardiovascular Events During Antihypertensive Treatment Hypertension ·Eva Gerdts, Kristian Wachtell, Per Omvik, Jan Erik Otterstad, Lasse Oikarinen, Kurt Boman, Björn Dahlöf, Richard B. Devereux	2006	159
9	Assessment of four ambulatory blood pressure monitors and measurements by clinicians versus intraarterial blood pressure at rest and during exercise The American Journal of Cardiology ·William B. White, Per Lund‐Johansen, Per Omvik	1990	142
10	β-2 Adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study Kidney International ·Bernd Timmermann, Ran Mo, Friedrich C. Luft, Eva Gerdts, Andreas Busjahn, Per Omvik, G H Li, H. Schuster, T. F. Wienker, Margret R. Hoehe, Per Lund‐Johansen	1998	122
11	Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy Journal of Hypertension ·Hans Ibsen, Kristian Wachtell, Michael Hecht Olsen, Knut Borch‐Johnsen, Lars Lindholm, Carl Erik Mogensen, (unknown), Richard B. Devereux, Ulf dé Fairé, Frej Fyhrquist, Stevo Julius, Sverre E. Kjeldsen, Ole Lederballe‐Pedersen, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Ying Wan	2004	96
12	Double-blind, parallel, comparative study on quality of life during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicentre study Journal of Hypertension ·Per Omvik, Erik Thaulow, O. B. Herland, Ivar Eide, R Midha, Ralph R. Turner	1993	80
13	Impact of New-Onset Diabetes Mellitus on Cardiac Outcomes in the Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) Trial Population Hypertension ·Tonje A. Aksnes, Sverre E. Kjeldsen, Morten Rostrup, Per Omvik, Tsushung A. Hua, Stevo Julius	2007	78
14	Hemodynamic and volume changes associated with captopril. Hypertension ·Robert C. Tarazi, E L Bravo, F. M. Fouad, Per Omvik, Robert Cody	1980	75
15	Stroke Reduction in Hypertensive Adults With Cardiac Hypertrophy Randomized to Losartan Versus Atenolol Hypertension ·Jorge R. Kizer, Björn Dahlöf, Sverre E. Kjeldsen, Stevo Julius, Gareth Beevers, Ulf dé Fairé, Frej Fyhrquist, Hans Ibsen, Krister Kristianson, Ole Lederballe‐Pedersen, Lars Lindholm, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel, Kristian Wachtell, Jonathan M. Edelman, Steven Snapinn, Katherine E. Harris, Richard B. Devereux	2004	72
16	Clinical evaluation of the Accutracker II ambulatory blood pressure monitor: assessment of performance in two countries and comparison with sphygmomanometry and intra-arterial blood pressure at rest and during exercise Journal of Hypertension ·William B. White, Per Lund‐Johansen, Ellen J. McCabe, Per Omvik	1989	69
17	Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise. British Journal of Clinical Pharmacology ·P Lund‐Johansen, Per Omvik, Helge Haugland	1986	57
18	Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: The LIFE study American Journal of Hypertension ·SE Kjeldsen, Björn Dahlöf, Richard B. Devereux, S Julius, Ulf dé Fairé, Frej Fyhrquist, Hans Ibsen, Krister Kristianson, Ole Lederballe‐Pedersen, Lars Lindholm, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel, (unknown)	2000	50
19	Regulation of sodium balance in hypertension. Hypertension ·Per Omvik, Robert C. Tarazi, Elena Bravo	1980	45
20	Haemodynamic Effects of Nifedipine in Essential Hypertension at Rest and During Exercise Journal of Hypertension ·Per Lund‐Johansen, Per Omvik	1983	42

About Per Omvik

Per Omvik is a scholar working on Cardiology and Cardiovascular Medicine, Complementary and alternative medicine, Nephrology, Endocrinology, Diabetes and Metabolism and Nutrition and Dietetics, having authored 125 papers that have together received 8.7k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (82 papers), Heart Rate Variability and Autonomic Control (35 papers), Cardiovascular and exercise physiology (30 papers), Hormonal Regulation and Hypertension (22 papers), Hemodynamic Monitoring and Therapy (14 papers), Cardiovascular Function and Risk Factors (14 papers), Sodium Intake and Health (13 papers) and Renin-Angiotensin System Studies (9 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (6.8k citations), Endocrinology, Diabetes and Metabolism (3.1k citations), Nephrology (958 citations), Nutrition and Dietetics (952 citations) and Pharmacology (677 citations). Per Omvik has collaborated with scholars based in Norway, United States and Sweden. Frequent co-authors include Sverre E. Kjeldsen, Stevo Julius, Markku S. Nieminen, Lars Lindholm, Hans Ibsen, Ole Lederballe‐Pedersen, Richard B. Devereux, Frej Fyhrquist, Ulf dé Fairé and Hans Wedel. Their work appears in journals such as Journal of Hypertension, Blood Pressure, Journal of Cardiovascular Pharmacology, Hypertension and Cardiovascular Drugs and Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact